MASSACHUSETTS INSTITUTE OF TECHNOLOGY

MIT researchers developed a gastric balloon controllable to feel full or not, aiding weight loss by reducing food intake by 60% in animals. The balloon is implanted and connected to an external device for inflation and deflation, addressing limitations of traditional gastric balloons.

USF Health and Weill Cornell Medicine published the first version of their clinically validated voice dataset on an AI platform, aiming to diagnose diseases like cancer and depression through voice analysis. The dataset includes over 12,500 recordings from 306 participants and will be expanded to 10,000 voices by the end of a four-year $14 million project. The data is standardized and includes respiratory, voice, and speech tasks, crucial for validating voice algorithms and developing new diagnostic methods.

Used MIMIC-III and eICU datasets for sepsis treatment model training, with 80% of MIMIC-III data for training and 20% for testing. Implemented Double-Dueling-Deep-Q-Network (DDDQN) with Highlight coefficient and over/under estimation monitoring for offline RL training.

Eisbach Bio relocates to Houston with a $4.75 million grant from the Cancer Prevention and Research Institute of Texas to develop EIS-12656, a cancer therapy targeting HRD tumors. The grant supports Phase 2 trials at MD Anderson Cancer Center, positioning Texas as a hub for innovative cancer treatments.

Cellino hosted its second annual Personalized RegenMed Forum, bringing together global innovators to explore the future of curative therapies and accelerate progress in regenerative medicine.

Lindus Health introduces an 'All-in-One Infectious Disease CRO' offering tailored for infectious disease trials, leveraging full-spectrum CRO and site services, innovative recruitment strategies, adaptable eClinical software, and regulatory insights. They aim to streamline clinical trial execution for infectious disease treatments and diagnostics.

WEF identifies 12 cancer breakthroughs, including personalized cancer vaccines, AI-driven early detection, and repurposed drugs for prevention, potentially leading to new clinical laboratory tests and diagnostics.

Elicio Therapeutics reports Q3 2024 financial results, anticipates AMPLIFY-7P Phase 2 enrollment completion in Q4 2024, with interim DFS analysis in H1 2025. Presented AMPLIFY-7P Phase 1a data at SITC 2024, showing durable T cell responses and antigen spreading in KRAS mutant tumors. Plans to update RFS and OS data from AMPLIFY-201 at 2024 ESMO Immuno-Oncology Congress. Strengthened cash position to support operations beyond the interim analysis.

A study shows the brain engages 24 networks/regions while watching movies, with executive control networks active during complex scenes and specialized regions during simple ones. Researchers used fMRI and AI to analyze brain activity in 176 young people watching movie clips, identifying how different networks respond to various movie elements.

2025 Medicare payment rates criticized by hospitals; mental health apps to be covered; insurers fear losses; Americans support higher Medicare premiums for Alzheimer's treatments; private Medicare plans for veterans; AdvaMed calls for supplemental breast cancer imaging coverage; longer hospice stays for dementia patients save Medicare; Biden promotes firearm safety counseling in Medicaid.